Trials / Completed
CompletedNCT00151528
An Open-Label Trial of Pregabalin in Patients With Fibromyalgia
A Long-Term, Open-Label, Safety Trial of Pregabalin in Patients With Fibromyalgia
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 428 (planned)
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The main purpose of this protocol is to evaluate the long-term safety of pregabalin in patients who participated in the previous fibromyalgia Study A0081056 and who wish to receive open-label pregabalin therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Pregabalin |
Timeline
- Start date
- 2005-01-01
- Completion
- 2006-06-01
- First posted
- 2005-09-09
- Last updated
- 2021-01-22
Locations
93 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00151528. Inclusion in this directory is not an endorsement.